Severity
Critical
FDA Drug recall · Reported December 31, 2014
Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.
Pharmacy Creations recalled Glutathione 100mg/mL Sterile Injection, 30 mL Multi Dose Vial, Rx only, Pharmacy Creation… - a critical-severity action.
Glutathione 100mg/mL Sterile Injection, 30 mL Multi Dose Vial, Rx only, Pharmacy Creation… was recalled by Pharmacy Creations in December 31, 2014. Reason: Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility in…. Check the official notice for the remedy. Verify recall #D-0306-2015 with the FDA Drug before acting.
The recall
Pharmacy Creations issued this critical-severity FDA Drug recall-Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility in….
Sourced from official FDA Drug enforcement records. Verify recall #D-0306-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0306-2015) was formally reported on December 31, 2014, with the manufacturer initiating the action on September 5, 2014. It is classified under Critical severity (Class I), with a current status of Terminated. Pharmacy Creations is listed as the recalling firm, operating out of Randolph, NJ. Federal records list the affected scope as 12 vials.
The documented reason for this recall is: Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile. Distribution data in the federal record shows the product reached: Directly to patients and physicians in FL, NJ, NY, and Puerto Rico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
12 vials
Related Recalls
6
5 from same agency
Glutathione 100mg/mL Sterile Injection, 30 mL Multi Dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.
Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0306-2015 |
| Date reported | December 31, 2014 |
| Date initiated | September 5, 2014 |
| Recalling firm | Pharmacy Creations |
| Firm location | Randolph, NJ |
| Affected scope | 12 vials |
| Distribution | Directly to patients and physicians in FL, NJ, NY, and Puerto Rico |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 31, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.